Assessment of Relative Bioavailability and Effect of Food on Capsule and Tablet Formulations of TP-3654
Status:
COMPLETED
Trial end date:
2023-08-24
Target enrollment:
Participant gender:
Summary
This study comprised of 2 parts, Part A and Part B. Part B will only be conducted if the relative bioavailability of the tablet formulation was at least 70% of the capsule formulation.